Hengshi Ophthalmology's shareholders Meixin Fund and Pengxin Fund intend to collectively reduce their holdings by no more than 0.83 million shares; Almaden's shareholder Lin Jinkun intends to reduce his shareholding by no more than 1.24%; Guangdong Dcenti Auto-Parts Stock's shareholder Taifeng International intends to reduce its shareholding by no more than 1%; ST Baili is suspected of violating disclosure regulations, and the CSRC has decided to initiate a case against the company and its controlling shareholder Wang Hairong; CSI All Share Investment Banking & Tianfeng Securities Co., Ltd. is not planning a merger or reorganization; *ST Zhongrun has terminated the private placement of stocks for the year 2022.